Purpose: We obtained peripheral blood monocytes from HIV-1-infected patients and differentiated them into macrophages in vitro to investigate the contribution of purified monocytes to plasma viremia in HIV-infected patients.
Method: We compared the production of HIV-1 from purified monocytes isolated from patients who were receiving antiviral therapy to those who were not. We obtained monocytes from 29 antiretroviral-naïve (ARVN) patients and 35 protease inhibitor (PI)-treated HIV-infected patients (20 with undetectable plasma HIV). Cells were cultured with phorbol myristate acetate to induce HIV replication.
Results: HIV p24 core antigen was present in supernatants of 9/29 (31%) of ARVN patients (mean = 102 pg/mL). In contrast to ARVN patients, p24 was not found in supernatants of any PI-treated patient (p =.01). Thus, purified monocytes from some ARVN patients produce HIV, but we were unable to detect HIV production from monocytes from PI-treated patients, regardless of their virologic response.
Conclusion: Monocytes may contribute to plasma viremia in ARVN patients but may not do so in PI-treated patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1310/EF26-V3PC-AG5X-FCF4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program.
Curr HIV Res
July 2009
Departments of Medicine, University of Washington, Seattle, IARTP, Box 359909, Washington 98104, USA.
Background: HIV treatment programs in Africa typically approach all enrolling patients uniformly. Growing numbers of patients are antiretroviral experienced. Defining patients on the basis of antiretroviral experience may inform enrollment practices, particularly if medical outcomes differ.
View Article and Find Full Text PDFHIV production from purified monocytes isolated from antiretroviral-naïve and protease inhibitor-treated HIV-1-infected patients.
HIV Clin Trials
February 2003
Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Health System, Ann Arbor 48109, USA.
Purpose: We obtained peripheral blood monocytes from HIV-1-infected patients and differentiated them into macrophages in vitro to investigate the contribution of purified monocytes to plasma viremia in HIV-infected patients.
Method: We compared the production of HIV-1 from purified monocytes isolated from patients who were receiving antiviral therapy to those who were not. We obtained monocytes from 29 antiretroviral-naïve (ARVN) patients and 35 protease inhibitor (PI)-treated HIV-infected patients (20 with undetectable plasma HIV).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!